Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry

Cell Stem Cell. 2016 Aug 4;19(2):154-157. doi: 10.1016/j.stem.2016.06.007. Epub 2016 Jun 30.


Direct-to-consumer marketing of unapproved stem cell interventions is a well-known phenomenon in countries with lax medical regulations. However, an examination of Internet-based marketing claims revealed widespread promotion of such interventions by businesses based in the United States. Such commercial activity suggests that regulatory agencies must better oversee this marketplace.

MeSH terms

  • Drug Industry / economics*
  • Drug Industry / ethics
  • Drug Industry / legislation & jurisprudence
  • Geography
  • Humans
  • Marketing* / ethics
  • Marketing* / legislation & jurisprudence
  • Policy
  • Risk
  • Stem Cells / cytology*
  • United States